Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!)
- Status
- RECRUITING
- Phase
- N/A
Statins and prOgression of Coronary atheRosclerosis in melanomA Patients Treated With chEckpoint inhibitorS
- Status
- RECRUITING
- Phase
- N/A
Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical Study
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
A Phase 1/2 Study of BA3071 in Patients With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
pRospective Evaluation of Clinical Outcomes in Patients With metAsTatIс melanOma Treated With dabrafeNib and trAmetinib in reaL practicE
- Status
- UNKNOWN
- Phase
- N/A
Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors
- Status
- TERMINATED
- Phase
- PHASE2
PD-L1 Targeting Nanobody Probe for PET Imaging of Solid Tumor
- Status
- UNKNOWN
- Phase
- NA
Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT4706 in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Exploring an Alternative Pre-operative SLN Mapping Method Using a Magnetic Tracer and MRI for Melanoma Patients
- Status
- UNKNOWN
- Phase
- NA
Zimberelimab (AB122) With TIGIT Inhibitor Domvanalimab (AB154) in PD-1 Relapsed/Refractory Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Proton Pencil Beam Scanning GRID for Treatment of Bulky Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Melanoma: Genomic Profiles, Molecular Markers and Therapeutic Implications
- Status
- UNKNOWN
- Phase
- N/A
Safety and Efficacy of Chimeric Antigen Receptor T Lymphocytes for Patients With Intermediate and Advanced Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Melanoma (Morpheus-Melanoma)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Adjuvant Melanoma Stakeholder Treatment Preferences
- Status
- COMPLETED
- Phase
- N/A
To Explore the Efficacy and Safety of SHR-1701 Combined With Temozolomide in the Treatment of Advanced Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma
- Status
- COMPLETED
- Phase
- N/A
Sitravatinib With or Without Tislelizumab in Patients With Unresectable or Metastatic Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2